Prostacyclin enhances stretch-induced surfactant secretion in alveolar epithelial type II cells

American Journal of Respiratory and Critical Care Medicine

Volumn 160, Issue 3, 1999, Pages 846-851

  Rose, Frank ^a   Zwick, Klaus ^a   Ghofrani, Hossein Ardeschir ^a   Sibelius, Ulf ^a   Seeger, Werner ^a   Walmrath, Dieter ^a   Grimminger, Friedrich ^a,b  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b Department of Internal Medicine ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; CYCLIC GMP; ILOPROST; LUNG SURFACTANT; NITRIC OXIDE; NITRIC OXIDE DONOR; PHOSPHATIDYLINOSITIDE; PHOSPHODIESTERASE; PROSTACYCLIN; SPERMINE;

ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL CELL; ARTICLE; CELL SURFACE; CONTROLLED STUDY; LUNG ALVEOLUS CELL TYPE 2; LUNG ALVEOLUS SURFACE TENSION; LUNG INFLATION; LUNG RECEPTOR; MALE; MECHANICAL STRESS; NONHUMAN; PHOSPHOINOSITIDE METABOLISM; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RAT;

EID: 0032849361     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.160.3.9812155     Document Type: Article

References (31)

1. Wirtz, H. R. W., and L. G. Dobbs. 1990. Calcium mobilization and exocytosis after one mechanical stretch of lung epithelial cells. Science 250:1266-1269.
2. Rooney, S. A., S. L. Young, and C. R. Mendelson. 1994. Molecular and cellular processing of lung surfactant. FASEB J. 8:957-967.
3. Wirtz, H. R. W., and M. Schmidt. 1992. Ventilation of pulmonary surfactant. Clin. Invest. 70:3-13.
4. Günther, A., C. Siebert, R. Schmidt, S. Ziegler, F. Grimminger, M. Yahut, B. Temmesfeld, D. Walmrath, H. Morr, and W. Seeger. 1996. Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema. Am. J. Respir. Crit. Care Med. 153(1):176-184.
5. Gregory, T. J., W. J. Longmore, M. A. Moxley, J. A. Whitsett, C. R. Reed, A. A. Fowler, III, L. D. Hudson, R. J. Maunder, C. Crim, and T. M. Hyers. 1991. Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J. Clin. Invest. 88(6): 1976-1981.
6. Rossaint, R., K. J. Falke, F. Lopez, K. Slama, U. Pison, and W. M. Zapol. 1993. Inhaled nitric oxide for the adult respiratory distress syndrome. N. Engl. J. Med. 328(6):399-405.
7. Walmrath, D., T. Schneider, J. Pilch, F. Grimminger, and W. Seeger. 1993. Aerosolized prostacyclin in adult respiratory distress syndrome. Lancet 342(8877):941-942.
8. Beloucif, S., and D. Payen. 1998. A European survey of the use of inhaled nitric oxide in the ICU: Working Group on Inhaled NO in the ICU of the European Society of Intensive Care Medicine. Intensive Care Med. 24(8):864-877.
9. Cuthbertson, B. H., P. Dellinger, O. J. Dyar, T. E. Evans, T. Higenbottam, R. Latimer, D. Payen, S. A. Stott, N. R. Webster, and J. D. Young. 1997. UK guidelines for the use of inhaled nitric oxide therapy in adult ICUs: American-European Consensus Conference on ALI/ ARDS. Intensive Care Med. 23(12):1212-1218.
10. Olschewski, H., D. Walmrath, R. Schermuly, A. Ghofrani, F. Grimminger, and W. Seeger. 1996. Aerosolized prostacyclin and iloprost in severe pulmonary hypertension. Ann. Intern. Med. 124(9):820-824.
11. Walmrath, D., T. Schneider, R. Schermuly, H. Olschewski, F. Grimminger, and W. Seeger. 1996. Direct comparison of inhaled nitric oxide and aerosolized prostacyclin in acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 153(3):991-996.
12. 2) versus inhaled nitric oxide in adult respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 154(6, Pt. 1):1671-1677.
13. Hallman, M., and K. Bry. 1996. Nitric oxide and lung surfactant. Semin. Perinatol. 20(3):173-185
14. Hallman, M., F. Waffarn, K. Bry, R. Turbow, M. T. Kleinman, W. J. Mautz, R. E. Rasmussen, D. K. Bhalla, and R. F. Phalen. 1996. Surfactant dysfunction after inhalation of nitric oxide. J. Appl. Physiol. 6: 2026-2034.
15. Robbins, C. G., J. M. Davis, T. A. Merritt, J. D. Amirkhanian, N. Sahgal, F. C. Morin, III, and S. Horowitz. 1995. Combined effects of nitric oxide and hypcroxia on surfactant function and pulmonary inflammation. Am. J. Physiol. 269(4, Pt. 1):L545-L550.
16. Ayad, O., and H. R. Wong. 1998. Nitric oxide decreases surfactant protein A gene expression in H441 cells. Crit. Care Med. 26(7):1277-1282.
17. Haddad, I. Y., J. P. Crow, P. Hu, Y. Ye, J. Beckman, and S. Matalon. 1994. Concurrent generation of nitric oxide and superoxide damages surfactant protein A. Am. J. Physiol. 267(3, Pt. 1):L242-L249.
18. Miles, P. R., L. Bowman, and L. Huffman. 1996. Nitric oxide alters metabolism in isolated alveolar type II cells. Am. J. Physiol. 271(1, Pt. I): L23-L30.
19. Haddad, I. Y., S. Zhu, J. Crow, E. Barefield, T. Gadilhe, and S. Matalon. 1996. Inhibition of alveolar type II cell ATP and surfactant synthesis by nitric oxide. Am. J. Physiol. 270(6, Pt 1):L898-L906.
20. Moncada, S., R. M. J. Palmer, and E. A. Higgs. 1991. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43:109.
21. Coleman, R. A., W. L. Smith, and S. Narumiya. 1994. International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol. Rev. 46(2):205-229.
22. Barnes, P. J. 1995. Cyclic nucleotides and phosphodiesterases and airway function. Eur. Respir. J. 8:457-462.
23. Dent, G., H. Magnussen, and K. F. Rabe. 1994. Cyclic nucleotide phosphodiesterases in the human lung. Lung 172:129-146.
24. Atkinson, P. H. 1975. Synthesis and assembly of HeLa cell plasma membrane glycoproteins and proteins. J. Biol. Chem. 250(6):2123-2134.
25. Berridge, M. J., R. M. C. Dawson, C. P. Downes, J. P. Heslop, and R. F. Irvine. 1983. Changes in the levels of inositol phosphates after agonist-dependent hydrolysis of membrane phosphoinositides. Biochem. J. 212: 473-482.
26. Felix, J. A., M. L. Woiodruff, and E. R. Dirksen. 1996. Stretch increases 1,4,5-triphosphate concentration in airway epithelial cells. Am. J. Respir. Mol. Biol. 14(3):296-301.
27. Rosales, O. R., and B. E. Sumpio. 1992. Changes in cyclic stretch increase inositol triphosphate and diacyglycerol in endothelial cells. Am. J. Physiol. 262:C956-C962.
28. Wise, H., and R. L. Jones. 1994. Characterization of prostanoid receptors on rat neutrophils. Br. J. Pharmacol. 113:581-587.
29. Namba, T., H. Oida, Y. Sugimoto, A. Kakizuka, M. Negishi, A. Ichikawa, and S. Narumiya. 1994. cDNA cloning of a mouse prostacyclin receptor: multiple signalling pathways and expression in thymic medulla. J. Biol. Chem. 269:9986-9992.
30. Giovanazzi, S., M. R. Accomazzo, O. Letari, D. Oliva, and S. Nicosia. 1997. Internalization and down regulation of the prostacyclin receptor in human platelets. Biochem. J. 325:71-77.
31. Fisch, A., K. Tobusch, K. Veit, J. Meyer, and H. Darius. 1997. Prostacyclin receptor desensitization is a reversible phenomenon in human platelets. Circulation 96:756-760.